Dr. Adele Hosseini, an accomplished executive in scientific and clinical affairs, with extensive experience in the pharmaceutical and biotech industry. She holds a PhD in Pharmacy from the University of Sydney and has contributed to drug development in various management and consultancy roles. Dr. Hosseini's experience in C-Suite roles and management positions in drug development and clinical research spans over three decades. Her expertise lies in developing comprehensive strategies that align with overarching business objectives. She is well-versed in drug development strategy and pathway, with a foundation of experience in leadership, global clinical research, regulatory affairs, and university lecturing. Her exposure across pharmaceuticals, clinical research organisations, medical devices, and academia has equipped her with the skills necessary to develop effective strategies and pathways for drug development.